Liver X receptor alpha splicing mutant protein, gene thereof and utilization of the same

Details for Australian Patent Application No. 2004238703 (hide)

Owner Sumitomo Chemical Company, Limited

Inventors Saito, Koichi; Fujimori, Ko

Agent Spruson & Ferguson

Pub. Number AU-B-2004238703

PCT Pub. Number WO2004/101616

Priority 2003-135461 14.05.03 JP

Filing date 13 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 24 July 2008

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/101616 Priority application(s): WO2004/101616

24 July 2008 Application Accepted

  Published as AU-B-2004238703

20 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238708-Crystal of benzimidazole derivative and process for producing the same

2004238689-Multilayer structure for packaging